Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project

Graziano, 1997, Non-small cell lung cancer: clinical value of new biological predictors, Lung Cancer, 17, S37, 10.1016/S0169-5002(97)00639-9

Kanters, 1995, Molecular and biological factors in the prognosis of non-small cell lung cancer, Eur Respir J, 8, 1389, 10.1183/09031936.95.08081389

Sculier, 1997, Facteurs pronostiques dans le cancer bronchique non à petites cellules avancé: expériences de l'European Lung Cancer Working Party, Rev Mal Respir, 14, 445

Mountain, 1997, Revisions in the international system for staging lung cancer, Chest, 111, 1710, 10.1378/chest.111.6.1710

Gould, 2001, Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis, JAMA, 285, 914, 10.1001/jama.285.7.914

Gould, 2003, Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis, Ann Intern Med, 139, 879, 10.7326/0003-4819-139-11-200311180-00013

Berghmans, 2005, Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: results of a meta-analysis of the literature, Lung Cancer, 49, 13, 10.1016/j.lungcan.2005.01.002

Meert, 2002, The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis, Eur Respir J, 20, 975, 10.1183/09031936.02.00296502

Parmar, 1998, Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints, Stat Med, 17, 2815, 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8

Yusuf, 1985, Beta blockade during and after myocardial infarction: an overview of the randomized trials, Prog Cardiovasc Dis, 27, 335, 10.1016/S0033-0620(85)80003-7

Port, 2005, Positron emission tomographic scanning in the diagnosis and staging of non-small cell lung cancer 2 cm in size or less, J Thorac Cardiovasc Surg, 130, 1611, 10.1016/j.jtcvs.2005.07.014

Marom, 2002, T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET, Radiology, 223, 453, 10.1148/radiol.2232011131

Cerfolio, 2005, The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival, J Thorac Cardiovasc Surg, 130, 151, 10.1016/j.jtcvs.2004.11.007

Borst, 2005, Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer, Eur J Cancer, 41, 1533, 10.1016/j.ejca.2005.03.026

Guo, 2004, In vitro proton magnetic resonance spectroscopic lactate and choline measurements, 18F-FDG uptake, and prognosis in patients with lung adenocarcinoma, J Nucl Med, 45, 1334

Higashi, 2002, 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cancer, J Nucl Med, 43, 39

Higashi, 2000, FDG PET in the evaluation of the aggressiveness of pulmonary adenocarcinoma: correlation with histopathological features, Nucl Med Commun, 21, 707, 10.1097/00006231-200008000-00002

Jeong, 2002, Determination of the prognostic value of [(18)F]fluorodeoxyglucose uptake by using positron emission tomography in patients with non-small cell lung cancer, Nucl Med Commun, 23, 865, 10.1097/00006231-200209000-00010

Eschmann, 2006, Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer?, Eur J Nucl Med Mol Imaging, 33, 263, 10.1007/s00259-005-1953-2

Dhital, 2000, [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer, Eur J Cardiothorac Surg, 18, 425, 10.1016/S1010-7940(00)00535-2

Prevost, 2006, Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer, J Nucl Med, 47, 559

Vansteenkiste, 1999, Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group, J Clin Oncol, 17, 3201, 10.1200/JCO.1999.17.10.3201

Sugawara, 1999, Does the FDG uptake of primary non-small cell lung cancer predict prognosis? A work in progress, Clin positron Imaging, 2, 111, 10.1016/S1095-0397(99)00012-6

Sasaki, 2005, [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer, J Clin Oncol, 23, 1136, 10.1200/JCO.2005.06.129

Downey, 2004, Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection, J Clin Oncol, 22, 3255, 10.1200/JCO.2004.11.109

Ahuja, 1998, The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma, Cancer, 83, 918, 10.1002/(SICI)1097-0142(19980901)83:5<918::AID-CNCR17>3.0.CO;2-Y

Leong, 1999, The 1997 International staging system for non-small cell lung cancer: have all the issues been addressed?, Chest, 115, 242, 10.1378/chest.115.1.242

Berghmans, 2004, Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy, Lung Cancer, 45, 339, 10.1016/j.lungcan.2004.02.016

Berghmans, 2006, Thyroid transcription factor 1—a new prognostic factor in lung cancer: a meta-analysis, Ann Oncol, 17, 1673, 10.1093/annonc/mdl287

Mascaux, 2005, The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis, Br J Cancer, 92, 131, 10.1038/sj.bjc.6602258

Choma, 2001, Aneuploidy and prognosis of non-small-cell lung cancer: a meta-analysis of published data, Br J Cancer, 85, 14, 10.1054/bjoc.2001.1892

Meert, 2002, The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis, Br J Cancer, 87, 694, 10.1038/sj.bjc.6600551

Steels, 2001, Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis, Eur Respir J, 18, 705, 10.1183/09031936.01.00062201

Meert, 2003, The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature, Br J Cancer, 89, 959, 10.1038/sj.bjc.6601252

Martin, 2003, Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis, Br J Cancer, 89, 55, 10.1038/sj.bjc.6601095

Delmotte, 2002, VEGF et survie des patients avec cancer pulmonaire: une revue systématique de la littérature et méta-analyse, Rev Mal Respir, 19, 577

van Baardwijk, 2007, The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer, Eur J Cancer, 43, 1392, 10.1016/j.ejca.2007.03.027

Auperin, 1999, Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group, N Engl J Med, 341, 476, 10.1056/NEJM199908123410703

Meert, 2001, Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis, BMC Cancer, 1, 5, 10.1186/1471-2407-1-5

Bacharach, 2002, 18F-FDG in cardiology and oncology: the bitter with the sweet, J Nucl Med, 43, 1542

Soret, 2007, Partial-volume effect in PET tumor imaging, J Nucl Med, 48, 932, 10.2967/jnumed.106.035774

Boellaard, 2004, Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study, J Nucl Med, 45, 1519

Krak, 2005, Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trial, Eur J Nucl Med Mol Imaging, 32, 294, 10.1007/s00259-004-1566-1

Kim, 1994, Standardized uptake values of FDG: body surface area correction is preferable to body weight correction, J Nucl Med, 35, 164

Langen, 1993, The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas, J Nucl Med, 34, 355

Zhuang, 2001, Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes, J Nucl Med, 42, 1412